World Heart Summit 2020
Date & Venue: March 12-13, 2020 | Singapore
Dialling number: +31 208 080 653
WhatsApp number: +31 649 708 123
Medical Conferences invites all the attendees from all over the world to attend the "World Heart Summit 2020" which is scheduled to be held on March 12-13, 2020 at Singapore.
This congress will assemble recent Researches & Findings, Oral talks, Poster Presentations, Exhibitions & other Cardiology related subjects and products.
Revolving around the theme "Revolutionizing the Researches and Innovations in Cardiac HealthCare” this Congress will provide an international platform for discussion of the present and future challenges in various kind of genetic and cardiovascular diseases, disorder, symptoms & analysis in regards to heart, along with education and expertise meeting on cardiology topics.
As we understand that "Life isn't measured in minutes but in Heartbeats" so this Heart 2020 will be an investigation of innovative researches in the field of Cardiology and spread the most recent advancements in heart disease prevention and rehabilitation. Argument on new technology enhancement in the field of Cardiovascular Disease and current practices in cardiovascular therapy, Cardiac progenitor cells, Hypertension for the primary care clinician, Stent procedure, Balloon Valvuloplasty, Coronary thrombectomy, Noninvasive cardiac imaging, Heart failure, Congestive heart failure, Sports Cardiology and more. Differentiating heart disease and other cardiac conditions constitute a team of healthcare professionals, of which the Cardiology technologist is a key player.
Heart 2020 will be a unique and international blend of big and small companies, leading universities, research institutions, and hospitals. This event aims to promote continuous medical education and encourage a nourishing exchange of facts and ideas about a healthy heart and ways to keep it healthy throughout the lifetime. This will be the best chance to impact the biggest convention of members from the Cardiology department. This Cardiologists Meet will see an amalgamation of expert Cardiologists, Scientists, Researchers, Professors, Nurses, Educators, Physicians, Surgeons, Pharmacists and other healthcare professionals along with various entrepreneurs and exhibitors. The Organizing Committee of Medical Conferences cordially invites all the people who are interested in the up-gradation of the healthcare requirements to maintain a healthy heart. We will all aim for a better and brighter future for this conference.
Associations and Societies
What is in stock for everyone at the conference?
For Researchers and Faculty Members
For Universities, Associations & Societies
For Students and Research Scholars
For Business Delegates
For Product Manufacturers
The World Heart Federation (WHF) joins 200 people navigating 100 countries in the fight against cardiovascular sickness Global Data inquire about predicts the general business division for CMD contraptions will reach $2.4 billion by 2020. The overall cardiovascular contraption industry is turning out to be rapidly and is said that an advancement of $15 billion is created utilizing 2010-2015 as indicated by BCC examine. Items fused into this business part are electrocardiograph watching outfit, which is set to see 6.5% improvement by 2024 to be worth over $720 million. The overall cardiovascular device industry is turning out to be rapidly improving and gives suggestions that it will continue progressing and develop to reach over $66.70 billion by 2024, up from just about $39.20 billion in 2017.
Highlights for the Heart 2020:
Track 1: Clinical Cardiology
Track 2: Heart Diseases & Heart Failure
Track 3: Cardiac Nursing & Healthcare
Track 4: Cardiac Surgery & Thoracic Surgery
Track 5: Cardiovascular Disease and Nutrition
Track 6: Cardio-Oncology & Radiotherapy
Track 7: Cardiomyopathies & Arrhythmias
Track 8: Heart Disease in Women
Track 9: Interventional Cardiology
Track 10: Myocardial Infarction
Track 11: Pediatric Cardiology
Track 12: Echocardiography
Track 13: Cardiac Regeneration
Track 14: Obesity, Stroke & Diabetes
Track 15: Diabetic Cardiovascular Disease
Track 16: Cardiovascular Pharmacology
Track 17: Cardiovascular Toxicity
Track 18: Vascular Biology
Track 19: Molecular and Cellular Cardiology
Track 20: Cardiac Rhythm Abnormalities
Track 21: Cardiac Perfusion
Track 22: Cardiac Electrophysiology
Track 23: Nuclear Cardiology and Cardiac CT
Track 24: Cardiovascular Rehabilitation
Track 25: Cardiovascular Imaging
Track 27: Cardiovascular Surgery
Track 28: Robotic Surgery
Track 29: Thyroid Disease and the Heart
Track 30: Percutaneous Coronary Interventions
Track 31: Hypertension & Atherosclerosis
Track 31: Digital Health and Cardiology
Track 32: Stem Cell Research on Cardiology & Regenerative Medicine
Track 33: Cardiovascular Medicine
Track 34: Cardiovascular Pharmacology
Track 35: Cardiovascular Treatment Devices (CRT/ICD)
Track 36: Cardiac Diagnostic Tests
Track 37: Cardiology: Future Medicine
Track 38: Medical Tourism in Cardiology
Track 39: Current Research in Cardiology
Track 40: Case Reports on Cardiology
Track 41: Telemedicine in Cardiology
Aim of this World Heart Summit 2020 is to ensure clinically appropriate cost effective care for your members with heart disease. It occurs mainly because of ischemic heart disease, stroke, dyslipidemia, thrombosis, atherosclerosis, coronary artery diseases, peripheral artery disease, hypertension and others. The main cause for this disorder includes obesity, high cholesterol, unhealthy dietary habits, lack of physical activity, smoking, excessive alcohol, and poor lifestyle. CVD is liable for approximately 15 million deaths each year across the globe and it also states that it is a major cause of death in adults that accounts for 50% of total deaths worldwide. A committed forum for the increasing, execution and exchange of information about Cardiovascular Medicine and its allied areas can be brought up by Organizing Conferences, National symposiums and Workshops.
Aetiology, Clinical characteristics and Therapy:
The aetiology of Heart Failure was hypertension in 45% of the patients while cardiomyopathies were behind 28%, rheumatic heart disease 12%, Ischemic heart disease 9% and other reasons (probable tuberculosis or HIV-related cardiomyopathies, endomyocardial fibrosis and obstructive lung disease) in 6%. is Among those with cardiomyopathies, Heart Failure due to idiopathic dilated cardiomyopathy was most frequent (81%), followed by postpartum cardiomyopathy (15%) while hypertrophic and restrictive cardiomyopathies were rare (5%). Rheumatic mitral disease with regurgitation was the most prevalent valvular lesion (81%), followed by mitral stenosis (15%) and aortic regurgitation (3%).
Why to attend?
Members from all over the world focused on learning about Cardiology, this is your single terrific opportunity to grasp the largest assemblage of participants from the hospitals, Universities, community, etc. This Cardiology Conference will be handling demonstrations, distribute information, meet with current and potential researchers and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the latest updates in Cardiology field are trademarks of this conference.
A prospective survey of patients with valvular heart disease (VHD):
With members from around the world focused on learning about Cardiology, this is your single best opportunity to reach the largest assemblage of participants from the hospitals, Universities, community, etc. This Heart Summit will conduct demonstrations, distribute information, meet with current and potential researchers and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Cardiology field are hallmarks of this conference.
The global cardiology market includes interventional, cardiac & cardiovascular devices. The global interventional cardiology devices market has been expected to grasp $25.16 billion by 2020. On the other hand, the Asia Pacific market is expected to go above $6.4 billion by 2022, growing at a lucrative rate over the forecast period. The global market for cardiovascular surgical devices used in the operating room was worth about $31 billion in 2010. By 2015, this market ranged almost $48 billion at a CAGR of 8.7%. By 2017, it is estimated to reach at a market value of $70. The growth is attributed to the presence of large initial opportunities, rising healthcare expense, cardiovascular disease incidence rate and disposable income levels. North America interventional cardiology devices market was the largest with revenue share estimated at over 35.0% in 2013. Europe was the second biggest area in 2014, with rising occurrences of obesity and changing lifestyle habits as- irregularities in diet and evolving number of smokers are responsible for the happening of cardiovascular disease prevalence. The advance of these products in this region also depends on the restitution policies given by each of the European nations. The Asia Pacific interventional cardiology devices market is habituated to be a bystander to significant gains, at a CAGR of over 9.0% from 2014 to 2020 due to the increasing popularity of cardiovascular disorders in geriatric and pediatric population, growing awareness about the cost efficacy and efficiency provided by these devices and rising health care expenditure levels.
Societies Associated With Cardiology